| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.46 | 0.006 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.33 | 0.008 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |